ESE-1 Activators are a class of compounds that enhance the functional activity of ESE-1 by acting on various cellular mechanisms. Forskolin, through the increase of cAMP, activates PKA which can phosphorylate and influence the transcriptional activity of ESE-1. This phosphorylation may enhance the binding of ESE-1 to DNA, facilitating its transcriptional efficacy. Epigallocatechin gallate and 5-Aza-2'-deoxycytidine reduce methylation of the ESE-1 promoter region, which may lead to augmented ESE-1 expression and subsequent transcriptional activity. Similarly, Sulforaphane, Trichostatin A, and Sodium butyrate, as HDAC inhibitors, increase histone acetylation, allowing for a more open chromatin structure and improved ESE-1 access to DNA, which enhances its transcriptional regulation capabilities.
Further, Retinoic acid can induce the expression of genes that act as co-factors or enhancers of ESE-1 activity, while Curcumin, by inhibiting NF-κB signaling, can reduce suppressive inflammatory signaling pathways that hinder ESE-1 activity. Resveratrol, through SIRT1 activation, can lead to deacetylation of histones and transcription factors, creating a conducive chromatin environment for ESE-1. Piceatannol and SP600125, by modulating kinase activities, indirectly influence the transcriptional programs that ESE-1 is a part of, enhancing its transcriptional output. Lithium chloride's inhibition of GSK-3 may also contribute to the stabilization of transcription factors or co-activators that enhance ESE-1's transcriptional activity.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
HDAC inhibitor that leads to hyperacetylation of histones, potentially enhancing ESE-1 activity by increasing the accessibility of ESE-1 to its target gene promoters. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor that can modulate AP-1 activity, potentially enhancing ESE-1 activity by altering the transcriptional regulation of genes that ESE-1 interacts with. | ||||||